ImmunoPrecise Antibodies Ltd.
IPA
$0.4606
$0.01062.36%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 251.86% | -10.47% | 12.56% | -45.73% | 7.04% |
| Total Receivables | -11.67% | 49.46% | -21.91% | -2.55% | -8.02% |
| Inventory | -8.03% | 6.61% | -13.06% | -17.76% | 7.19% |
| Prepaid Expenses | -39.38% | -4.62% | 21.55% | -25.63% | 1.50% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 59.74% | 12.47% | -4.56% | -25.73% | 1.45% |
|
|
|||||
| Total Current Assets | 59.74% | 12.47% | -4.56% | -25.73% | 1.45% |
| Net Property, Plant & Equipment | -8.18% | -3.76% | -2.04% | -1.79% | 44.80% |
| Long-term Investments | -4.30% | 0.04% | 1.57% | -59.91% | 2.39% |
| Goodwill | -4.30% | 0.04% | 1.57% | -59.91% | 2.39% |
| Total Other Intangibles | -95.30% | -2.64% | -1.06% | -17.64% | -0.12% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.55% | 0.00% | 1.45% | -5.36% | 25.60% |
| Total Assets | -26.89% | 0.24% | -1.64% | -25.79% | 8.04% |
|
|
|||||
| Total Accounts Payable | -33.06% | -21.35% | 10.35% | 24.06% | 22.25% |
| Total Accrued Expenses | 1.63% | 494.71% | -65.00% | -48.11% | 18.64% |
| Short-term Debt | -- | 17.97% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.10% | 2.59% | 2.17% | -13.95% | 92.39% |
| Total Finance Division Other Current Liabilities | 20.90% | 4.61% | 30.94% | -36.86% | 6.13% |
| Total Other Current Liabilities | 20.90% | 4.61% | 30.94% | -36.86% | 6.13% |
| Total Current Liabilities | -30.69% | 10.09% | 36.84% | -12.95% | 25.18% |
|
|
|||||
| Total Current Liabilities | -30.69% | 10.09% | 36.84% | -12.95% | 25.18% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 17.97% | -- | -- | -- |
| Capital Leases | -7.27% | -2.76% | -2.32% | -6.55% | 52.02% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -92.86% | -5.81% | -42.33% | -20.82% | 0.16% |
| Total Liabilities | -27.98% | 2.28% | 0.94% | -12.10% | 27.12% |
|
|
|||||
| Common Stock & APIC | 6.34% | 0.77% | -0.01% | -1.42% | 4.70% |
| Retained Earnings | -16.00% | -1.59% | -1.77% | -18.71% | -7.66% |
| Treasury Stock & Other | -8.69% | 5.61% | 27.60% | 28.09% | -17.09% |
| Total Common Equity | -25.97% | -1.41% | -3.63% | -33.72% | -0.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -25.97% | -1.41% | -3.63% | -33.72% | -0.61% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -25.97% | -1.41% | -3.63% | -33.72% | -0.61% |
|
|
|||||